Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interstitial Colloidal 32P in Non-Resectable Pancreatic Cancer
NCT00002689Phase 2Completed
- Sponsor
- Center for Molecular Medicine
- Start
- Sep 1995
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of phosphorus-32 colloid in pancreatic cancer (PC), sponsored by Center for Molecular Medicine. Primary endpoints: Response Rate, Duration of Remission and 2 more. Started Sep 1995; status: completed.
02
Drugs
phosphorus-32 colloid
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00002689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002689.